rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2011-3-10
|
pubmed:abstractText |
To assess the efficiency of IIb/IIIa platelet receptor inhibition by abciximab in the prevention of silent embolism during digital subtraction angiography.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1421-9786
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright © 2011 S. Karger AG, Basel.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
353-7
|
pubmed:meshHeading |
pubmed-meshheading:21212667-Angiography, Digital Subtraction,
pubmed-meshheading:21212667-Antibodies, Monoclonal,
pubmed-meshheading:21212667-Brain Ischemia,
pubmed-meshheading:21212667-Cerebral Angiography,
pubmed-meshheading:21212667-Diffusion Magnetic Resonance Imaging,
pubmed-meshheading:21212667-Double-Blind Method,
pubmed-meshheading:21212667-Female,
pubmed-meshheading:21212667-Germany,
pubmed-meshheading:21212667-Humans,
pubmed-meshheading:21212667-Immunoglobulin Fab Fragments,
pubmed-meshheading:21212667-Intracranial Embolism,
pubmed-meshheading:21212667-Male,
pubmed-meshheading:21212667-Middle Aged,
pubmed-meshheading:21212667-Placebo Effect,
pubmed-meshheading:21212667-Platelet Aggregation Inhibitors,
pubmed-meshheading:21212667-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:21212667-Prospective Studies,
pubmed-meshheading:21212667-Risk Factors,
pubmed-meshheading:21212667-Treatment Failure
|
pubmed:year |
2011
|
pubmed:articleTitle |
Abciximab does not prevent ischemic lesions related to cerebral angiography: a randomized placebo-controlled trial.
|
pubmed:affiliation |
Department of Neuroradiology, Medical Faculty Mannheim, University of Heidelberg, Germany. caro.brockmann@gmx.de
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|